Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Introduction

Considerable progress has been made in the treatment of skin diseases. Nevertheless, such diseases still remain common in many rural communities in developing countries, with serious economic and social consequences as well as health implications. Directly or indirectly, skin diseases are responsible for much disability (and loss of economic potential), disfigurement, and distress due to symptoms such as itching or pain.

The diseases covered in this volume are mostly very common, although some rare, life-threatening disorders such as pemphigus are discussed briefly. The aim is to provide the basic information necessary to treat skin diseases in the community, with particular emphasis on those diseases prevalent in developing countries. The book does not attempt to provide a detailed guide to the management of skin diseases.

Given reliable access to preparations contained in WHO’s Model List of Essential Drugs,1 many skin diseases are curable or controllable. However, it is recognized that factors such as poor housing, inadequate nutrition, unsanitary conditions and environmental pollution may also contribute to the prevalence of such diseases and should also be addressed when required.

1The use of essential drugs. Seventh report of the WHO Expert Committee. Geneva, World Health Organization, 1997 (WHO Technical Report Series, No. 867).

In general, conditions in which skin involvement is only one manifestation of a more generalized systemic infectious disease, such as leprosy, mycobacterial diseases, leishmaniasis, onchocerciasis, human immunodeficiency virus (HIV) infection and syphilis, are excluded from this volume. Further details of the treatment of some of these conditions can be found in the volumes on drugs used in mycobacterial diseases,1 parasitic diseases2 and sexually transmitted diseases and HIV infection.3

1WHO model prescribing information: drugs used in mycobacterial diseases. Geneva, World Health Organization, 1991.

2WHO model prescribing information: drugs used in parasitic diseases, 2nd ed. Geneva, World Health Organization, 1995.

3WHO model prescribing information: drugs used in sexually transmitted diseases and HIV infection. Geneva, World Health Organization, 1995.

 

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019